Is it growing?
Is SUPN growing?
Supernus Pharmaceuticals, Inc. has grown revenue 5.1% a year over three years and 6.9% a year over five.
+5.1%
Revenue growth, 3-year annual rate · Drug Manufacturers - Specialty & Generic median +15% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue
- Revenue growth, 5-year rate
- +6.9%
Revenue growth, 5-year rate · +5.1% over three · growth has slowed since the five-year average
- Years of annual history on file
- 16
Years of annual history on file · FY2010 to FY2025, as filed
Details›
- Revenue FY2021
- $580M
- Revenue FY2022
- $667M
- Revenue FY2023
- $608M
- Revenue FY2024
- $662M
- Revenue FY2025
- $719M
Annual income statements as filed with the SEC.
Drug Manufacturers - Specialty & Generic
Ranks #19 of 28 by Smart Score